The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.
 
Raquibul Hannan
Research Funding - Dendreon (Inst); Prometheus (Inst)
 
Michael Christensen
No Relationships to Disclose
 
Aurelie Garant
No Relationships to Disclose
 
Hans J. Hammers
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - ARMO BioSciences; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; exelixis; Lilly; Merck; Novartis; Pfizer; Surface Oncology
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Novartis; Pfizer
 
Waddah Arafat
Stock and Other Ownership Interests - Myovant Sciences
Research Funding - Seattle Genetics/Astellas (Inst)
 
Kevin Dale Courtney
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Exelixis
Research Funding - Amgen (Inst); Aragon Pharmaceuticals (Inst); Astellas Pharma; Astellas Pharma (Inst); Astellas Pharma (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Peloton Therapeutics (Inst); Proacta (Inst); Stemline Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
Isaac Alex Bowman
Consulting or Advisory Role - Dendreon; Foundation Medicine
 
Suzanne Cole
Research Funding - Exelixis (Inst); Merck Sharp & Dohme (Inst)
 
David Sher
No Relationships to Disclose
 
Chul Ahn
Leadership - Eutilex; Psomagen
Stock and Other Ownership Interests - Psomagen
Consulting or Advisory Role - IQVIA; Macrogen; PPD Global; Syneos Health
Travel, Accommodations, Expenses - Macrogen
 
Robert D. Timmerman
Research Funding - Accuray (Inst); Elekta (Inst); Varian Medical Systems (Inst)
 
James Brugarolas
Consulting or Advisory Role - Arrowhead Pharmaceuticals; Calithera Biosciences; Exelixis
Research Funding - Arrowhead Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Non-invasive PET tracer to evaluate HIF2alpha (Inst); Patent of HIF-2 biomarker (Inst); Patent pertaining HIF2a resistance mutations (Inst)
Travel, Accommodations, Expenses - Exelixis